APA

Lledó A., Dellva M. A., Strombom I. M., Wilkie J. L., Jungemann M. E., Royer M. G., Simmons V. E. & Cavazzoni P. A. (20070710). Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. : European journal of neurology.

Chicago

Lledó A, Dellva M A, Strombom I M, Wilkie J L, Jungemann Mark E, Royer M G, Simmons V E and Cavazzoni P A. 20070710. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. : European journal of neurology.

Harvard

Lledó A., Dellva M. A., Strombom I. M., Wilkie J. L., Jungemann M. E., Royer M. G., Simmons V. E. and Cavazzoni P. A. (20070710). Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. : European journal of neurology.

MLA

Lledó A, Dellva M A, Strombom I M, Wilkie J L, Jungemann Mark E, Royer M G, Simmons V E and Cavazzoni P A. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists. : European journal of neurology. 20070710.